CYTOGEN RECORDS GREATER LOSSCytogen Corp. (NASDAQ:CYTO) of Princeton, N.J., said fourth-quarter revenues declined 64 percent from the comparable1989 quarter, when it booked $2 million in non-recurringpayments associated with the signing of a marketingagreement.

Fourth quarter ended Dec. 29(Figures in thousands except per-share data.)

1990 1989 Percent change

Revenues 944 2,655 -64Net income (loss) (4,596) (2,978) -54Net income per share (loss) (.32) (.26) -23Outstanding shares 15,840 12,096 +31

Year ended Dec. 29(Figures in thousands except per-share data.)

1990 1989 Percent change

Revenues 4,701 7,468 -37Net income (loss) (17,339) (13,956) -24Net income per share (loss) (1.36) (1.18) -15Outstanding shares 13,971 11,994 +16

GREENWICH PHARMACEUTICALS REPORTS DEEPER LOSS

Greenwich Pharmaceuticals Inc. (NASDAQ:GRPI) of FortWashington, Pa., attributed increased revenues for the fiscalyear to the receipt of a technology transfer fee from KisseiPharmaceuticals Co. Ltd. last June, sales of chemicals related tothe development and manufacture of carbohydrate drugs andhigher interest earned on the company's investments.

Fourth quarter ended Dec. 31(Figures in thousands except per-share data.)

1990 1989 Percent change

Revenues 1,129 734 +54Net income (loss) (3,284) (1,841) -78Net income per share (loss) (.14) (.09) -56Outstanding shares 23,559 21,230 +11

Year ended Dec. 31

(Figures in thousands except per-share data.)

1990 1989 Percent change

Revenues 6,247 2,826 +121Net income (loss) (8,673) (8,686) negl.Net income per share (loss) (.38) (.42) +10Outstanding shares 22,852 20,854 +10

INCSTAR POSTS PROFITABLE FOURTH QUARTER

Incstar Inc. (ASE:ISR) of Stillwater, Minn., said sales from allsectors increased in 1990, and that fourth-quarter resultsbenefitted from net operating loss carryforwards amounting to$455,000 in the fourth quarter.

Fourth quarter ended Dec. 31(Figures in thousands except per-share data.)

1990 1989 Percent change

Revenues 7,368 5,176 +42Net income (loss) 1,048 (4,282) n.a.Net income per share (loss) .07 (.78) n.a.Outstanding shares 16,001,707 5,477,536 +192

Year ended Dec. 31(Figures in thousands except per-share data.)

1990 1989 Percent change

Revenues 27,003 19,519 +38Net income (loss) 2,974 (5,827) n.a.Net income per share (loss) .20 (1.56) n.a.Outstanding shares 15,064,107 3,733,384 +303

BECKMAN INSTRUMENTS PROFITS SLIP

Beckman Instruments (NYSE:BEC) of Fullerton, Calif., said thatfluctuations in foreign currency exchange rates had the effectof raising reported sales revenues for 1990 by $23.6 million,including $14 million in the fourth quarter.

Fourth quarter ended Dec. 31(Figures in thousands except per-share data.)

1990 1989 Percent change

Revenues 225,800 199,700 +13Net income 10,000 10,400 -4Net income per share .35 .36 -3Outstanding shares 28,808 28,500 +1

Year ended Dec. 31(Figures in thousands except per-share data.)

1990 1989 Percent change

Revenues 815,200 785,900 +4Net income 36,200 41,900 -14Net income per share 1.26 1.47 -14Outstanding shares 28,728 28,500 negl.

(c) 1997 American Health Consultants. All rights reserved.